Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Radiotherapy for Refractory Hidradenitis Suppurativa [NA]

View source ↗

Summary

This clinical trial update notes that Thomas Jefferson University is evaluating radiotherapy for refractory hidradenitis suppurativa. The study status is NOT_YE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radiotherapy

Snippet

Sponsor: Thomas Jefferson University | Conditions: Hidradenitis Suppurativa (HS) | NA | Status: NOT_YET_RECRUITING